CFTC and DOJ Sue Louisiana and Arkansas as Federal-State Fight Turns Openly Hostile
Louisiana Attorney General Liz Murrill won a temporary restraining order on November 12 against 31 prediction market entities, including Kalshi, Polymarket, Robinhood, and Coinbase, with a preliminary injunction hearing set for November 30. The CFTC — now joined by the Department of Justice — sued both Louisiana and Arkansas to block the state enforcement, marking Louisiana as the twelfth state the agency has taken to court. The dispute has turned personal: Murrill called CFTC Chairman Michael Selig an 'obsequious standard bearer' for the platforms, while Selig characterised her lawsuit as 'naked lawfare.' The DOJ's involvement escalates the federal response beyond the CFTC acting alone.
Louisiana Attorney General Liz Murrill brought an enforcement action on November 12, 2026 against Kalshi, Polymarket, Robinhood, Coinbase, and other operators, obtaining a temporary restraining order within hours covering 31 entities. The order bars the named operators from offering event contracts in Louisiana, lasts 10 days unless extended, and is set for a preliminary injunction hearing on November 30. The next day, the CFTC — joined by the Department of Justice — sued Louisiana in the US District Court for the Eastern District of Louisiana, seeking to invalidate the order and confirm the products fall under exclusive federal oversight through the Commodity Exchange Act. The CFTC said Louisiana is the twelfth state it has sued. The agency and DOJ separately sued Arkansas to halt AG Tim Griffin's lawsuit against Kalshi.
For UK readers, the Department of Justice's involvement is the significant escalation. For most of 2026 the federal defence was conducted by the CFTC alone — an independent regulator asserting jurisdiction through civil litigation. The DOJ joining the suits brings the executive branch's principal law-enforcement authority into the fight on the platforms' side, signalling that the federal government treats state enforcement against CFTC-registered exchanges as warranting the full weight of federal litigation. It reframes the matter from a regulator-versus-state jurisdictional dispute into the United States government asserting federal supremacy against state interference with federally regulated commerce.
The rhetoric has escalated alongside the litigation. Louisiana AG Murrill publicly called CFTC Chairman Michael Selig an 'obsequious standard bearer' for Kalshi and the industry — accusing the agency's chief of aligning with the companies he regulates. Selig characterised Murrill's lawsuit as 'naked lawfare,' the use of legal process as a weapon rather than good-faith enforcement. The exchange shows how far the federal-state relationship has deteriorated. Selig has also warned states against bringing criminal charges against prediction market executives, a reference to the felony charges Utah filed against Kalshi's founders in late October. The confrontation is no longer a measured disagreement about statutory interpretation; it is an openly adversarial fight with a state attorney general and a federal agency chairman trading accusations of bad faith.
The litigation also expands the circuit footprint. Arkansas sits in the Eighth Circuit, already weighing Kalshi's Iowa appeal and governing the Missouri litigation; the Arkansas suit adds another Eighth Circuit case to that docket. Louisiana sits in the Fifth Circuit, which has not yet ruled on the preemption question — so the Louisiana litigation could make the Fifth Circuit the next appeals court to weigh in, after the Third, Ninth, Sixth, and the pending Eighth. The proliferation continues the pattern that has defined the dispute: the question is litigated in parallel across the judiciary, new states join faster than any case resolves, and the federal government's offensive races against state courts that have already stripped the platforms' federal shield in several jurisdictions. The November 30 Louisiana hearing and the approaching December 5 deadline on the CFTC's geofencing demand mean the collision between federal directives and state court orders will intensify further before any of it reaches the Supreme Court.
Operators mentioned in this article
Recent updates
CFTC Orders Kalshi to Halt 'Trump Mention' Markets — the Agency Restrains Its Own Protégé
The CFTC notified Kalshi that its 'mention' markets — contracts on what President Trump will say — are under a formal stay, forcing an indefinite pause pending a review of whether the contracts are 'readily susceptible to manipulation.' Kalshi has until December 11 to defend the products, and its CEO reportedly disagrees with the suspension. The action is notable because the CFTC has spent 2026 defending Kalshi against state enforcement; here the same agency is restricting one of Kalshi's own product lines.
Fourth Circuit Rules Against Kalshi in Maryland — Circuit Split Widens to 3-1 With a Notable Dissent
A divided Fourth Circuit panel ruled 2-1 on November 17 that Maryland gaming regulators can pursue enforcement against Kalshi over unlicensed sports betting, rejecting the platform's CFTC-preemption argument. Judge DeAndrea Benjamin dissented, arguing that Kalshi's sports event contracts are 'swaps' under exclusive CFTC oversight — the first appellate dissent on the pro-Kalshi side. The ruling makes the Fourth Circuit the third appeals court to rule against Kalshi, deepening the split to three circuits against (Fourth, Sixth, Ninth) and one for (Third), with the Supreme Court cert petition pending.
Kalshi and Polymarket Expand Into Health Contracts — Measles, Drug Trials, FDA Approvals Draw Scrutiny
Kalshi and Polymarket have added event contracts tied to US public health outcomes, including measles case-count thresholds settled using CDC data, clinical drug-trial results, and FDA regulatory approvals. Two Democratic senators wrote to the Department of Health and Human Services on November 11 raising concerns about the drug-trial and FDA markets, particularly the risk that people with confidential access to trial data or agency decisions could profit from disclosing it. Kalshi says it has implemented guardrails, such as limiting markets to late-stage trials. The expansion extends the debate over whether some prediction market categories commodify sensitive public outcomes in harmful ways.